(Q38136569)

29 August 2017

title

What the genetics of lipodystrophy can teach us about insulin resistance and diabetes (English)

1 reference

29 August 2017

1 reference

Camille Vatier

1

1 reference

29 August 2017

Guillaume Bidault

2

1 reference

29 August 2017

Nolwenn Briand

3

1 reference

29 August 2017

Anne-Claire Guénantin

4

1 reference

29 August 2017

Laurence Teyssières

5

1 reference

29 August 2017

Olivier Lascols

6

1 reference

29 August 2017

Jacqueline Capeau

7

1 reference

29 August 2017

Corinne Vigouroux

8

1 reference

29 August 2017

publication date

1 December 2013

1 reference

29 August 2017

published in

Current diabetes report

1 reference

29 August 2017

volume

13

1 reference

29 August 2017

issue

6

1 reference

29 August 2017

page(s)

757-767

1 reference

https://scigraph.springernature.com/pub.10.1007/s11892-013-0431-7

29 August 2017

exact match

0 references

cites work

Clinical review#: Lipodystrophies: genetic and acquired body fat disorders

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Molecular mechanisms of human lipodystrophies: from adipocyte lipid droplet to oxidative stress and lipotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

LMNA, encoding lamin A/C, is mutated in partial lipodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

A family with severe insulin resistance and diabetes due to a mutation in AKT2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Perilipin deficiency and autosomal dominant partial lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A/C

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Lamin a truncation in Hutchinson-Gilford progeria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Recurrent de novo point mutations in lamin A cause Hutchinson–Gilford progeria syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress and premature cellular senescence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

PSMB8 encoding the β5i proteasome subunit is mutated in joint contractures, muscle atrophy, microcytic anemia, and panniculitis-induced lipodystrophy syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

A mutation in the immunoproteasome subunit PSMB8 causes autoinflammation and lipodystrophy in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Possible involvement of the adipose tissue renin-angiotensin system in the pathophysiology of obesity and obesity-related disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Adipose tissue lymphocytes: types and roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Life without white fat: a transgenic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Transplantation of adipose tissue lacking leptin is unable to reverse the metabolic abnormalities associated with lipoatrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Acquired and inherited lipodystrophies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Fertility and obstetrical complications in women with LMNA-related familial partial lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Congenital Generalized Lipodystrophy Accompanied by Cystic Angiomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Genetic Syndromes of Severe Insulin Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

PIK3R1 mutations cause syndromic insulin resistance with lipoatrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Phenotypic Heterogeneity in Body Fat Distribution in Patients with Congenital Generalized Lipodystrophy Caused by Mutations in the AGPAT2 or Seipin Genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Lysophospholipid acyltransferases: 1-acylglycerol-3-phosphate O-acyltransferases. From discovery to disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Alterations in lipid signaling underlie lipodystrophy secondary to AGPAT2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Seipin: from human disease to molecular mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

The lipodystrophy protein seipin is found at endoplasmic reticulum lipid droplet junctions and is important for droplet morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Seipin deficiency alters fatty acid Delta9 desaturation and lipid droplet formation in Berardinelli-Seip congenital lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Controlling the size of lipid droplets: lipid and protein factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Seipinopathy: a novel endoplasmic reticulum stress-associated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Alleviation of seipinopathy-related ER stress by triglyceride storage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Heterozygous CAV1 frameshift mutations (MIM 601047) in patients with atypical partial lipodystrophy and hypertriglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Accumulation of caveolin in the endoplasmic reticulum redirects the protein to lipid storage droplets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

A caveolin dominant negative mutant associates with lipid bodies and induces intracellular cholesterol imbalance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

The lipoatrophic caveolin-1 deficient mouse model reveals autophagy in mature adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Lipid droplet analysis in caveolin-deficient adipocytes: alterations in surface phospholipid composition and maturation defects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Nuclear lamins and laminopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

The nuclear lamins: flexibility in function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Phenotypic gender differences in subjects with familial partial lipodystrophy (Dunnigan variety) due to a nuclear lamin A/C R482W mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

LMNA mutations induce a non-inflammatory fibrosis and a brown fat-like dystrophy of enlarged cervical adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermic papules, liver steatosis, and cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Atypical progeroid syndrome due to heterozygous missense LMNA mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Altered pre-lamin A processing is a common mechanism leading to lipodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Adult stem cell maintenance and tissue regeneration in the ageing context: the role for A-type lamins as intrinsic modulators of ageing in adult stem cells and their niches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Lamin complexes in the nuclear interior control progenitor cell proliferation and tissue homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Fat and beyond: the diverse biology of PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Functional implications of genetic variation in human PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Peroxisome proliferator-activated receptor-γ mutations responsible for lipodystrophy with severe hypertension activate the cellular renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Human frame shift mutations affecting the carboxyl terminus of perilipin increase lipolysis by failing to sequester the adipose triglyceride lipase (ATGL) coactivator AB-hydrolase-containing 5 (ABHD5)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Sequencing of the reannotated LMNB2 gene reveals novel mutations in patients with acquired partial lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

HIV protease inhibitors block the zinc metalloproteinase ZMPSTE24 and lead to an accumulation of prelamin A in cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Partial lipodystrophy with severe insulin resistance and adult progeria Werner syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

An in-frame deletion at the polymerase active site of POLD1 causes a multisystem disorder with lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Gluteofemoral body fat as a determinant of metabolic health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Eucaloric Substitution of Medium Chain Triglycerides for Dietary Long Chain Fatty Acids in Acquired Total Lipodystrophy: Effects on Hyperlipoproteinemia and Endogenous Insulin Resistance*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Genetic basis of lipodystrophies and management of metabolic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Leptin-replacement therapy for lipodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Long-term efficacy of leptin replacement in patients with generalized lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Leptinomimetic effects of the AMP kinase activator AICAR in leptin-resistant rats: prevention of diabetes and ectopic lipid deposition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Lamin A/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0431-7

Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis

21 January 2018

1 reference

12 December 2020

Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome--an allostatic perspective

1 reference

12 December 2020

Generalized lipodystrophy, congenital and acquired (lipoatrophy).

1 reference

12 December 2020

Cell death-inducing DFF45-like effector, a lipid droplet-associated protein, might be involved in the differentiation of human adipocytes

1 reference

12 December 2020

Phenotypic diversity in patients with lipodystrophy associated with LMNA mutations

1 reference

12 December 2020

Effect of leptin replacement on pituitary hormone regulation in patients with severe lipodystrophy.

1 reference

12 December 2020

Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension

1 reference

12 December 2020

Adipose tissue as an endocrine organ

1 reference

12 December 2020

The secretory face of the adipose cell: a tribute to two queens, leptin and adiponectin

1 reference

12 December 2020

Surgical management of phenotypic alterations related to the Dunnigan variety of familial partial lipodystrophy

1 reference

12 December 2020

A homozygous mutation of prelamin-A preventing its farnesylation and maturation leads to a severe lipodystrophic phenotype: new insights into the pathogenicity of nonfarnesylated prelamin-A

1 reference

12 December 2020

Familial lipoatrophic diabetes with dominant transmission. A new syndrome.

1 reference

12 December 2020

A Chinese patient with acquired partial lipodystrophy caused by a novel mutation with LMNB2 gene.

1 reference

12 December 2020

Dual-energy X-ray absorptiometry study of body composition in patients with lipodystrophy

1 reference

12 December 2020

Localized involutional lipoatrophy: a clinicopathologic study of 16 patients

1 reference

12 December 2020

Homozygous lamin A/C familial lipodystrophy R482Q mutation in autosomal recessive Emery Dreifuss muscular dystrophy

1 reference

12 December 2020

Estimation of adipose tissue mass by magnetic resonance imaging: validation against dissection in human cadavers

1 reference

12 December 2020

Adipose tissue distribution pattern in patients with familial partial lipodystrophy (Dunnigan variety)

1 reference

12 December 2020

Higher adiponectin levels in patients with Berardinelli-Seip congenital lipodystrophy due to seipin as compared with 1-acylglycerol-3-phosphate-o-acyltransferase-2 deficiency

1 reference

12 December 2020

Serum adiponectin and leptin levels in patients with lipodystrophies

1 reference

12 December 2020

10.1007/S11892-013-0431-7

Identifiers

DOI

1 reference

Dimensions Publication ID

29 August 2017

1027382618

0 references

1 reference